Ledger.Open graph →
SEC Form D · filed May 17, 2023

Eureka Therapeutics, Inc

Offering
$20.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Emeryville, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Wai-Yan "Sandy" Chau · Emeryville, CADirectorReed Jobs · Emeryville, CADirectorVictor S. Shum · Emeryville, CAExecVivien S. Chan · Emeryville, CAExecCheng Liu · Hong Kong, IsraelExec · DirectorMichael Cannon · San Diego, CADirectorMarvin Samson · PARSIPPANY, NJDirectorWilliam S. Solari Iii · Emeryville, CADirectorJacqueline Northcut · Emeryville, CADirectorChih-Kai "C.K. Cheng · Emeryville, CADirectorVivien S. Chan · Emeryville, CAExecCheng Liu · Emeryville, CAExec · DirectorMichael Cannon · San Diego, CADirectorMarvin Samson · Emeryville, CADirectorWilliam S. Solari Iii · Emeryville, CADirectorWai-Yan "Sandy" Chau · Emeryville, CADirectorReed Jobs · Emeryville, CADirectorVictor S. Shum · Emeryville, CAExecJacqueline Northcut · Emeryville, CADirectorChih-Kai "C.K. Cheng · Emeryville, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗